OCULAR THERAPEUTIX IN
9.0900
25-十一月-24 15:45:01
15 分钟延时
股票
+0.2600
+2.94%
今日范围
8.7795 - 9.1300
ISIN
N/A
来源
NASDAQ
-
Ocular Therapeutix™ Reports Third Quarter 2024 Results and Business Highlights
14 11月 2024 06:00:01 条件 Nasdaq GlobeNewswire
-
13 11月 2024 06:30:00 条件 Nasdaq GlobeNewswire
-
Ocular Therapeutix™ Appoints Namrata Saroj, OD, as Chief Business Officer
12 11月 2024 06:30:00 条件 Nasdaq GlobeNewswire
-
Ocular Therapeutix™ to Report Third Quarter 2024 Results on November 14, 2024
06 11月 2024 06:30:00 条件 Nasdaq GlobeNewswire
-
NetDania - New 12 months High: OCULAR THERAPEUTIX INC. - COMMON STOCK
28 10月 2024 09:00:04 条件 NetDania Notify
-
NetDania - New 12 months High: OCULAR THERAPEUTIX INC. - COMMON STOCK
21 10月 2024 08:47:37 条件 NetDania Notify
-
NetDania - New 12 months High: OCULAR THERAPEUTIX INC. - COMMON STOCK
16 10月 2024 14:33:40 条件 NetDania Notify
-
15 10月 2024 06:30:00 条件 Nasdaq GlobeNewswire
-
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
09 10月 2024 15:05:00 条件 Nasdaq GlobeNewswire
-
Ocular Therapeutix™ to Present at October Ophthalmology Meetings
09 10月 2024 06:30:00 条件 Nasdaq GlobeNewswire
-
Ocular Therapeutix™ to Present at the UBS Virtual Opthalmology Day 2024
25 9月 2024 06:30:00 条件 Nasdaq GlobeNewswire
-
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
12 9月 2024 15:05:00 条件 Nasdaq GlobeNewswire
-
Ocular Therapeutix™ to Present at September Retina Meetings
05 9月 2024 06:30:00 条件 Nasdaq GlobeNewswire
-
Ocular Therapeutix™ to Present at Two Investor Conferences in September
04 9月 2024 06:30:00 条件 Nasdaq GlobeNewswire
-
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09 8月 2024 06:30:00 条件 Nasdaq GlobeNewswire
-
Ocular Therapeutix™ Reports Second Quarter 2024 Results
07 8月 2024 06:10:00 条件 Nasdaq GlobeNewswire
-
07 8月 2024 06:00:00 条件 Nasdaq GlobeNewswire
-
Ocular Therapeutix™ to Report Second Quarter 2024 Financial Results on August 7, 2024
31 7月 2024 06:30:00 条件 Nasdaq GlobeNewswire
-
Ocular Therapeutix™ Announces First Patients Enrolled in Phase 3 SOL-R Wet AMD Study
30 7月 2024 06:30:00 条件 Nasdaq GlobeNewswire
-
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
18 7月 2024 15:05:00 条件 Nasdaq GlobeNewswire
- <<
- <
- 1
- >